Chikungunya IgG and IgM Cassette (WB/S/P)

Chikungunya is a mosquito-borne viral infection transmitted mainly by infected Aedes mosquitoes. It may cause fever, rash, headache, body pain, muscle pain, and severe joint pain. Symptoms may overlap with other mosquito-borne infections such as dengue and Zika, so diagnostic testing can support clinical evaluation. The Chikungunya IgG and IgM Cassette is designed to detect both IgM and IgG antibodies, helping identify recent, later-stage, or past immune response patterns.

• The Chikungunya IgG and IgM Cassette is useful where fast screening is needed, especially in areas where mosquito-borne infections are common.
• IgM antibodies generally indicate recent infection, while IgG antibodies may indicate later-stage or past exposure.
• Testing for both IgG and IgM can provide broader screening support compared with IgM-only testing, especially when the timing of infection is unclear.
• From an international diagnostic supply point of view, the Chikungunya IgG and IgM Rapid Test is valuable for laboratories, healthcare procurement agencies, hospitals, clinics, distributors, and public health programs that require rapid infectious disease testing.

The Chikungunya IgG and IgM Cassette (WB/S/P) by LARKSOIS Pharma may be used in professional diagnostic and healthcare environments.

Applications

• Suspected chikungunya infection screening
• Hospitals and clinical laboratories
• Diagnostic centers and clinics
• Fever and mosquito-borne disease screening workflows
• Public health screening programs
• Field healthcare programs
• International diagnostic distribution
• Professional laboratory testing workflows

• The Chikungunya IgG and IgM Rapid Test Cassette works through lateral flow / chromatographic immunoassay technology.
• A whole blood, serum, or plasma specimen is added to the cassette along with buffer according to the kit instructions.
• If Chikungunya IgG or IgM antibodies are present, visible test lines appear in the test region.
• A control line confirms that the test has run properly. The result should always be read according to the official LARKSOIS Pharma product insert.

The Chikungunya IgG and IgM Cassette uses a rapid chromatographic immunoassay method for qualitative detection of Chikungunya IgG and IgM antibodies.

Benefits

• Rapid screening for suspected chikungunya infection
• Detects both IgG and IgM antibodies
• Suitable for whole blood, serum, or plasma
• Easy visual result interpretation
• No major equipment requirement
• Useful for clinics, hospitals, laboratories, and distributors
• Supports infectious disease testing programs
• Suitable for international diagnostic product supply

The Chikungunya IgG and IgM Cassette is designed for whole blood, serum, or plasma specimens. Correct specimen collection and handling are important for reliable screening performance.

Guidance

• Use whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable specimen collection materials
• Avoid contaminated or improperly stored samples
• Apply the specimen and buffer as instructed
• Read results only within the recommended time window
• Treat all specimens as potentially infectious material

Note

Specimen collection, handling, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

• The Chikungunya IgG and IgM Cassette should be used as a screening aid, not as the only basis for diagnosis.
• A reactive result should be interpreted with symptoms, travel history, exposure risk, and additional laboratory findings.
• IgM may suggest recent infection, while IgG may suggest later-stage or past exposure.
• Reactive specimens may require confirmation using alternative testing methods and clinical findings depending on local diagnostic guidance.

The Chikungunya IgG and IgM Cassette is intended as a qualitative screening aid and should not be used as the only basis for diagnosis or treatment decisions.

Instructions

• A positive result suggests Chikungunya IgG and/or IgM antibody detection but does not confirm disease severity
• A negative result does not always rule out chikungunya infection
• Testing too early after symptom onset may affect antibody detection
• Improper specimen collection or storage may affect results
• Results should be interpreted with clinical findings and exposure history
• Additional laboratory testing may be required depending on clinical condition
• Final diagnosis should be made by qualified healthcare professionals

Instructions

• Rapid screening for suspected chikungunya infection
• Detects both IgG and IgM antibodies
• Suitable for whole blood, serum, or plasma
• Easy visual result interpretation
• Useful for clinics, hospitals, laboratories, and distributors
• Supports infectious disease testing programs
• Suitable for international diagnostic product supply
• Professional rapid diagnostic test format

Note

The Chikungunya IgG and IgM Cassette by LARKSOIS Pharma is developed for professional users who need fast and practical infectious disease screening support.

Steps

• Bring the test device, specimen, and buffer to the recommended testing condition if required
• Open the sealed pouch only when ready to test
• Collect whole blood, serum, or plasma according to the product insert
• Apply the required specimen volume to the test cassette
• Add buffer according to the official kit instructions
• Wait for the test reaction to complete within the stated time
• Read the result within the approved interpretation window
• Dispose of used materials according to laboratory safety rules

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the Chikungunya IgG and IgM Cassette (WB/S/P).

Positive

A positive result suggests that Chikungunya IgG and/or IgM antibodies may be present in the specimen. IgM may suggest recent infection, while IgG may suggest later-stage or past exposure. The result should be interpreted with clinical symptoms, exposure history, and other laboratory findings.

Negative

A negative result suggests that Chikungunya IgG and IgM antibodies were not detected or were below the test detection level at the time of testing. A negative result does not always rule out chikungunya infection.

Invalid

If the control line does not appear, the result is invalid. The test should be repeated with a new device and properly collected specimen according to the product insert.

Instructions

• Store the test device according to the product label instructions
• Keep the cassette sealed until use
• Protect from moisture
• Avoid direct sunlight and extreme temperatures
• Do not use expired or damaged test kits
• Allow test components and specimens to reach room temperature before testing if required
• Follow standard biosafety practices while handling whole blood, serum, or plasma specimens

Instructions

• For professional in-vitro diagnostic use only
• Do not reuse the cassette
• Use only suitable specimens: whole blood, serum, or plasma
• Read results within the recommended time window
• Negative results do not completely rule out infection
• Positive results should be reviewed with clinical findings
• Follow local diagnostic and reporting guidelines
• Follow laboratory biosafety and disposal procedures

LARKSOIS Pharma provides international-quality diagnostic and pharmaceutical products for global healthcare markets. The Chikungunya IgG and IgM Cassette is designed for professional testing environments that need fast, simple, and dependable infectious disease rapid testing solutions.

Advantages

• International diagnostic product focus
• Reliable rapid testing solutions
• Suitable for hospitals, laboratories, and clinics
• Distributor-friendly product format
• Supports infectious disease screening workflows
• Practical mosquito-borne disease testing support
• Quality-focused standards under LARKSOIS Pharma